{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:08:34Z","timestamp":1788847714013,"version":"build-2803163510"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Canadian Menopause Society"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>STUDY QUESTION<\/jats:title>\n                    <jats:p>What is the incidence of premature ovarian insufficiency (POI) and its associated factors in Ontario, Canada, between 1995 and 2019?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY ANSWER<\/jats:title>\n                    <jats:p>The incidence of POI increased after 2011, driven primarily by non-iatrogenic POI, and was highest among women with a history of endometriosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                    <jats:p>Recent estimates suggest a global POI prevalence of \u223c3.7%, with increasing rates over time. POI has heterogeneous etiologies, including genetic, autoimmune, infectious, and iatrogenic causes; however, the cause remains unknown in \u223c70% of non-iatrogenic cases. Existing incidence estimates are limited by recall bias, cross-sectional designs, small sample sizes, and limited assessment of associated factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                    <jats:p>This population-based cohort study included all women aged \u2264 39\u2009years residing in Ontario between 1995 and 2019. Follow-up continued until POI diagnosis, age 40\u2009years, death, loss of provincial health insurance, or end of the study period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                    <jats:p>POI was defined using administrative health data as a diagnosis occurring before age 40\u00a0years identified by either (i) surgical menopause or (ii) \u22651 physician consultation coded as menopause (ICD-9 627). Annual incidence rates (IRs) were calculated using census data, with the Ontario female population aged \u2264 39\u2009years as the denominator. POI was classified as non-iatrogenic, surgical, post-chemotherapy and\/or radiotherapy, or combined surgical with chemotherapy and\/or radiotherapy. Associations between clinical factors and POI were estimated using age-adjusted modified Poisson regression to derive incidence rate ratios (IRRs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                    <jats:p>Among 3\u00a0635\u00a0702 eligible women, 168\u00a0173 developed POI from any etiology (IR 389.4 per 100\u00a0000 person-years). Median follow-up was 11\u2009years (IQR 6\u201318), and median age at POI diagnosis was 31\u2009years (IQR 25\u201336). IRs were 351.4 per 100\u00a0000 person-years for non-iatrogenic POI, 30.2 for surgical POI, 5.5 for post-chemotherapy and\/or radiotherapy POI, and 2.3 for combined surgical with chemotherapy and\/or radiotherapy POI. Overall POI incidence declined between 2002 and 2008, followed by a sustained increase through 2019, largely attributable to non-iatrogenic POI. The incidence of surgically induced POI decreased from 60 per 100\u00a0000 person-years in 1995 to 20 in 2019, while combined surgical with chemotherapy and\/or radiotherapy POI increased steadily over the study period. Factors associated with higher POI incidence included endometriosis (IRR 3.45, 95% CI 3.39, 3.52), cancer treated with chemotherapy or radiotherapy (IRR 2.01, 95% CI 1.89, 2.14), drug or tobacco use (IRR 1.59, 95% CI 1.51, 1.67), chromosomal disorders (IRR 1.50, 95% CI 1.42, 1.59), and autoimmune diseases (IRR 1.19, 95% CI 1.17, 1.22).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                    <jats:p>Use of administrative health data may result in outcome misclassification and limited availability of detailed clinical and demographic information.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                    <jats:p>These findings provide contemporary population-based estimates of POI incidence and identify endometriosis as a major associated factor. The marked decline in surgically induced POI over time suggests increased adoption of ovarian-preserving surgical approaches, while rising non-iatrogenic POI incidence underscores the need for improved risk stratification, counselling, and further studies to elucidate underlying mechanisms and modifiable risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>FUNDING<\/jats:title>\n                    <jats:p>Canadian Menopause Society.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCLOSURES<\/jats:title>\n                    <jats:p>Nothing to disclose.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                    <jats:p>N\/A.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/humrep\/deag111","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:42:31Z","timestamp":1784090551000},"page":"1612-1621","source":"Crossref","is-referenced-by-count":0,"title":["Incidence and factors associated with premature ovarian insufficiency: a population-based cohort study"],"prefix":"10.1093","volume":"41","author":[{"given":"J N","family":"Macintyre","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Queen\u2019s University , Kingston, ON,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7000-2605","authenticated-orcid":false,"given":"J","family":"Pudwell","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Queen\u2019s University , Kingston, ON,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Shellenberger","sequence":"additional","affiliation":[{"name":"ICES , Toronto, ON,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4834-8279","authenticated-orcid":false,"given":"M P","family":"Velez","sequence":"additional","affiliation":[{"name":"ICES , Toronto, ON,","place":["Canada"]},{"name":"Department of Obstetrics and Gynecology, McGill University , Montreal, QC,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"2026090801515826700_deag111-B1","doi-asserted-by":"crossref","first-page":"E227","DOI":"10.9778\/cmajo.20220144","article-title":"Endometriosis and cardiovascular disease: a population-based cohort study","volume":"11","author":"Blom","year":"2023","journal-title":"CMAJ Open"},{"key":"2026090801515826700_deag111-B2","doi-asserted-by":"crossref","first-page":"102798","DOI":"10.1016\/j.jogc.2025.102798","article-title":"Endometriosis as a risk factor for ischemic and hemorrhagic stroke: a population-based cohort study","volume":"47","author":"Bougie","year":"2025","journal-title":"J Obstet Gynaecol Can"},{"key":"2026090801515826700_deag111-B3","doi-asserted-by":"crossref","first-page":"270.e1","DOI":"10.1016\/j.ajog.2021.04.237","article-title":"Long-term follow-up of endometriosis surgery in Ontario: a population-based cohort study","volume":"225","author":"Bougie","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"2026090801515826700_deag111-B4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jmig.2025.03.003","article-title":"Impact of surgeon characteristics on endometriosis surgery outcomes","volume":"32","author":"Bougie","year":"2025","journal-title":"J Minim Invasive Gynecol"},{"key":"2026090801515826700_deag111-B5","volume-title":"Canadian Cancer Statistics 2023","author":"Canadian Cancer Society","year":"2023"},{"key":"2026090801515826700_deag111-B6","doi-asserted-by":"crossref","first-page":"S340","DOI":"10.1016\/j.jogc.2019.09.002","article-title":"Hysterectomy trends: a Canadian perspective on the past, present, and future","volume":"41","author":"Chen","year":"2019","journal-title":"J Obstet Gynaecol Can"},{"key":"2026090801515826700_deag111-B7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12978-022-01559-8","article-title":"Premature ovarian insufficiency in female adolescent and young adult survivors of non-gynecological cancers: a population-based cohort study","volume":"20","author":"Flatt","year":"2023","journal-title":"Reprod Health"},{"key":"2026090801515826700_deag111-B8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/13697137.2019.1574738","article-title":"The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis","volume":"22","author":"Golezar","year":"2019","journal-title":"Climacteric"},{"key":"2026090801515826700_deag111-B9","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1210\/jc.2016-3960","article-title":"Premature ovarian insufficiency: phenotypic characterization within different etiologies","volume":"102","author":"Jiao","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2026090801515826700_deag111-B10","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s10815-019-01572-0","article-title":"Premature ovarian insufficiency (POI) and autoimmunity-an update appraisal","volume":"36","author":"Kirshenbaum","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"2026090801515826700_deag111-B11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/13697137.2022.2153033","article-title":"The global prevalence of premature ovarian insufficiency: a systematic review and meta-analysis","volume":"26","author":"Li","year":"2023","journal-title":"Climacteric"},{"key":"2026090801515826700_deag111-B12","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s11764-023-01388-z","article-title":"Chemotherapy alone vs. chemotherapy plus radiotherapy in female adolescent and young adults with Hodgkin\u2019s lymphoma: reproductive health outcomes","volume":"18","author":"Luong","year":"2024","journal-title":"J Cancer Surviv"},{"key":"2026090801515826700_deag111-B13","doi-asserted-by":"crossref","first-page":"E688","DOI":"10.1503\/cmaj.250439","article-title":"Risk of congenital anomalies among infants of patients with endometriosis: a population-based cohort study","volume":"198","author":"Milne","year":"2026","journal-title":"CMAJ"},{"key":"2026090801515826700_deag111-B14","first-page":"88","article-title":"The effect of laparoscopic endometrioma surgery on anti-Mullerian hormone: a systematic review of the literature and meta-analysis","volume":"26","author":"Moreno-Sepulveda","year":"2022","journal-title":"JBRA Assist Reprod"},{"key":"2026090801515826700_deag111-B15","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.fertnstert.2018.06.025","article-title":"Antimullerian hormone is reduced in the presence of ovarian endometriomas: a systematic review and meta-analysis","volume":"110","author":"Muzii","year":"2018","journal-title":"Fertil Steril"},{"key":"2026090801515826700_deag111-B16","doi-asserted-by":"crossref","first-page":"hoae065","DOI":"10.1093\/hropen\/hoae065","article-title":"Evidence-based guideline: premature ovarian insufficiency","volume":"2024","author":"Panay","year":"2024","journal-title":"Hum Reprod Open"},{"key":"2026090801515826700_deag111-B17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/13697137.2020.1804547","article-title":"Premature ovarian insufficiency: an International Menopause Society White Paper","volume":"23","author":"Panay","year":"2020","journal-title":"Climacteric"},{"key":"2026090801515826700_deag111-B18","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/GME.0000000000001729","article-title":"Early and surgical menopause associated with higher Framingham Risk Scores for cardiovascular disease in the Canadian Longitudinal Study on Aging","volume":"28","author":"Price","year":"2021","journal-title":"Menopause"},{"key":"2026090801515826700_deag111-B19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/cge.12921","article-title":"Genetics of primary ovarian insufficiency","volume":"91","author":"Rossetti","year":"2017","journal-title":"Clin Genet"},{"key":"2026090801515826700_deag111-B20","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.3390\/curroncol29110677","article-title":"Reproductive outcomes in young breast cancer survivors treated (15-39) in Ontario, Canada","volume":"29","author":"Rushton","year":"2022","journal-title":"Curr Oncol"},{"key":"2026090801515826700_deag111-B21","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jogc.2016.12.005","article-title":"No. 344 \u2013 Opportunistic salpingectomy and other methods of risk reduction for ovarian\/fallopian tube\/peritoneal cancer in the general population","volume":"39","author":"Salvador","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"2026090801515826700_deag111-B22","doi-asserted-by":"crossref","first-page":"101323","DOI":"10.1016\/j.beem.2019.101323","article-title":"Insights into the autoimmune aspect of premature ovarian insufficiency","volume":"33","author":"Sharif","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2026090801515826700_deag111-B23","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/humrep\/deac014","article-title":"Incidence and familial risk of premature ovarian insufficiency in the Finnish female population","volume":"37","author":"Silv\u00e9n","year":"2022","journal-title":"Hum Reprod"},{"key":"2026090801515826700_deag111-B24","doi-asserted-by":"crossref","first-page":"1073261","DOI":"10.3389\/fendo.2022.1073261","article-title":"Impacts of endometrioma on ovarian aging from basic science to clinical management","volume":"13","author":"Tan","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026090801515826700_deag111-B25","doi-asserted-by":"crossref","first-page":"649.e1","DOI":"10.1016\/j.ajog.2024.01.023","article-title":"Endometriosis and mental health: a population-based cohort study","volume":"230","author":"Thiel","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"2026090801515826700_deag111-B26","doi-asserted-by":"crossref","first-page":"12492","DOI":"10.1073\/pnas.1323955111","article-title":"Interleukin-1 deficiency prolongs ovarian lifespan in mice","volume":"111","author":"Uri-Belapolsky","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026090801515826700_deag111-B27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/gme.0b013e3181ceca7a","article-title":"Life course socioeconomic adversity and age at natural menopause in women from Latin America and the Caribbean","volume":"17","author":"Velez","year":"2010","journal-title":"Menopause"},{"key":"2026090801515826700_deag111-B28","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/GME.0000000000001362","article-title":"Age at natural menopause and physical functioning in postmenopausal women: the Canadian Longitudinal Study on Aging","volume":"26","author":"Velez","year":"2019","journal-title":"Menopause"},{"key":"2026090801515826700_deag111-B29","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.fertnstert.2022.09.015","article-title":"Mode of conception in patients with endometriosis and adverse pregnancy outcomes: a population-based cohort study","volume":"118","author":"Velez","year":"2022","journal-title":"Fertil Steril"},{"key":"2026090801515826700_deag111-B30","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/aje\/kwx292","article-title":"Cigarette smoking and risk of early natural menopause","volume":"187","author":"Whitcomb","year":"2018","journal-title":"Am J Epidemiol"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/41\/9\/1612\/68839840\/deag111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/41\/9\/1612\/68839840\/deag111.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:52:07Z","timestamp":1788846727000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/41\/9\/1612\/8734383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,7,15]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deag111","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,7,15]]}}}